| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $161.3M | $155.0M | $166.4M |
| YoY Revenue Growth % | +4.0% | -6.8% | — |
| Gross Profit | $77.4M | $71.9M | — |
| Gross Margin % | 48.0% | 46.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.8M | -$23.7M | -$28.9M |
| Operating Margin % | -7.3% | -15.3% | -17.4% |
| Net Income (GAAP) | -$9.9M | -$20.0M | $0 |
| EBITDA (Normalized) | -$11.5M | -$23.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$4.7M | -$1.0M | -$16.3M |
| Capital Expenditures (CapEx) | $307.0K | $283.0K | — |
| Free Cash Flow (FCF) | -$5.0M | -$1.3M | -$16.3M |
| FCF Margin % | -3.1% | -0.8% | -9.8% |
| Return on Invested Capital (ROIC %) | -36.3% | -45.0% | — |
| Cash & Short-Term Equivalents | $25.4M | $30.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $51.0M | $64.9M | — |